Metformin for Diabetes During Pregnancy
Metformin Improves Most Outcomes for Diabetes During Pregnancy (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 20, 2020 Category: General Medicine Source Type: news

Some Types of Metformin Recalled Due to Cancer Risk
Experts explain the back-and-forth on this popular diabetes drug ... If you take metformin to help manage diabetes, take note: Despite recent warnings and partial recalls by the Food and Drug Admin... (Source: AARP.org News)
Source: AARP.org News - November 16, 2020 Category: American Health Source Type: news

Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 500 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 500 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 500 mg have been found to contain levels of nitrosamine impurities above the ADI limit of 96 ng/day as publish (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 3, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Kansas City, Missouri, Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 750 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg have been found to contain levels of nitrosamine impurities above the ADI limit (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 2, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Use of Common Meds Tied to Lower Lung Cancer Mortality
Combined use of aspirin, statins, metformin tied to lower lung cancer risk and mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 17, 2020 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

Use of Common Meds Tied to Lower Lung Cancer Mortality
FRIDAY, Oct. 16, 2020 -- Use of aspirin, metformin, and statins is associated with a lower risk for lung cancer mortality, according to a study published online Sept. 17 in the Journal of Thoracic Oncology. Jihun Kang, M.D., from Kosin University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2020 Category: Pharmaceuticals Source Type: news

Hidradenitis Suppurativa Therapy Options Should Be Patient Guided Hidradenitis Suppurativa Therapy Options Should Be Patient Guided
A modern approach to hidradenitis suppurativa that incorporates such strategies as lasers, marsupialization, and metformin is built on a strategy individualized to the patient ' s most challenging symptoms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news

Recall Widens for Diabetes Drug Metformin Recall Widens for Diabetes Drug Metformin
More than 175 different drug combinations have been recalled since late May.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Recall Widens for Diabetes Drug Metformin
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 13, 2020 Category: General Medicine Source Type: news

Sun Pharma recalls 747 bottles of generic diabetes drug from the American market
As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), Sun Pharmaceutical Industries is recalling the bottles of RIOMET ER (metformin hydrochloride for extended-release oral suspension) in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 11, 2020 Category: Pharmaceuticals Source Type: news

'Don't panic.' Anti-diabetes medication recalled, may contain high levels of cancer-causing compound
Marksans Pharma and Sun Pharmaceutical Industries recalled metformin this week due to high levels of a cancer-causing compound,... (Source: Reuters: Health)
Source: Reuters: Health - October 9, 2020 Category: Consumer Health News Source Type: news

Widely Used Diabetes Drug Recalled For High Levels Of Cancer-Causing Agent
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p2").init({"mcp":"cbs","width":"100%","height":"100%","video":"4777335","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p2","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5"},"comscore":{"clientId"...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 9, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Diabetes Recall Source Type: news

Metformin Linked to Reduced Cognitive Decline, Dementia Risk Metformin Linked to Reduced Cognitive Decline, Dementia Risk
Rates of dementia, cognitive decline in people with type 2 diabetes taking metformin were similar to those without diabetes.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - October 7, 2020 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news

Marksans Pharma Limited Issues Expansion of Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Marksans Pharma Limited, India is voluntarily expanding its earlier initiated recall on June 05, 2020 to include an additional 76 unexpired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg,& 750mg to the consumer level. Marksans performed N-Nitrosodimethylamine (NDMA) testing of (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

University of Minnesota receives seed funding for clinical study of metformin to treat, prevent COVID-19
(University of Minnesota Medical School) University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 25, 2020 Category: International Medicine & Public Health Source Type: news